Consun Pharmaceutical Group Limited
CPHGF
$1.08
$0.0747.34%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 529.61M | 551.10M | 492.81M | 495.98M | 505.32M |
Total Receivables | 50.71M | 52.77M | 37.71M | 37.96M | 43.71M |
Inventory | 43.23M | 44.98M | 50.13M | 50.46M | 54.28M |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 3.25M | 3.27M | -- |
Total Current Assets | 623.54M | 648.84M | 583.91M | 587.66M | 603.32M |
|
|||||
Total Current Assets | 623.54M | 648.84M | 583.91M | 587.66M | 603.32M |
Net Property, Plant & Equipment | 126.80M | 131.95M | 120.50M | 121.27M | 121.81M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 36.85M | 38.34M | 37.25M | 37.49M | 39.93M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 10.71M | 11.15M | 11.16M | 11.23M | 10.41M |
Total Assets | 801.89M | 834.43M | 755.46M | 760.32M | 776.77M |
|
|||||
Total Accounts Payable | 10.36M | 10.78M | 5.76M | 5.80M | 11.72M |
Total Accrued Expenses | 100.85M | 104.94M | 83.56M | 84.10M | 90.08M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 35.59M | 37.03M | 70.43M | 70.88M | 71.59M |
Total Finance Division Other Current Liabilities | 41.00M | 42.67M | 31.02M | 31.22M | 37.44M |
Total Other Current Liabilities | 41.00M | 42.67M | 31.02M | 31.22M | 37.44M |
Total Current Liabilities | 187.80M | 195.42M | 190.77M | 192.00M | 210.83M |
|
|||||
Total Current Liabilities | 187.80M | 195.42M | 190.77M | 192.00M | 210.83M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1.01M | 1.06M | 495.00K | 498.20K | 549.70K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 11.21M | 11.67M | 14.98M | 15.08M | 12.75M |
Total Liabilities | 200.03M | 208.14M | 206.25M | 207.57M | 224.13M |
|
|||||
Common Stock & APIC | 38.88M | 40.45M | 33.80M | 34.02M | 11.56M |
Retained Earnings | 500.08M | 520.37M | 458.26M | 461.20M | 476.75M |
Treasury Stock & Other | 22.42M | 23.33M | 17.29M | 17.40M | 23.13M |
Total Common Equity | 561.38M | 584.16M | 509.35M | 512.62M | 511.43M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 561.38M | 584.16M | 509.35M | 512.62M | 511.43M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 40.48M | 42.12M | 39.87M | 40.13M | 41.21M |
Total Equity | 601.86M | 626.28M | 549.22M | 552.75M | 552.64M |
|